wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26829939-71CC0ED9-5288-49AF-A725-20F4EB3A729B
Q26829939-71CC0ED9-5288-49AF-A725-20F4EB3A729B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829939-71CC0ED9-5288-49AF-A725-20F4EB3A729B
Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer
P2860
Q26829939-71CC0ED9-5288-49AF-A725-20F4EB3A729B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829939-71CC0ED9-5288-49AF-A725-20F4EB3A729B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e722577400975607300e607c8f3b0af82bbc5bd8
P2860
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.